(Press-News.org) Contact information: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Researchers design global HIV vaccine that shows promise in monkeys
Preclinical study provides strong rationale for clinical trials
BOSTON -- The considerable diversity of HIV worldwide represents a critical challenge for designing an effective HIV vaccine. Now, a scientific team led by Beth Israel Deaconess Medical Center (BIDMC) has shown that bioinformatically optimized HIV vaccine antigens known as "mosaic" antigens might be useful in the design of a global HIV vaccine. This study, which was conducted in monkeys, is published today in the journal Cell.
"A global HIV vaccine would offer major biomedical and practical advantages over most other HIV vaccine candidates, which are limited to certain regions of the world," says lead author Dan H. Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at BIDMC, Director of the Vaccine Program at the Ragon Institute of MGH, MIT and Harvard, and Professor of Medicine at Harvard Medical School. "To our knowledge, this study represents the first evaluation of the protective efficacy of a candidate global HIV antigen strategy in nonhuman primates."
In this new publication, the authors demonstrate for the first time that mosaic HIV vaccine antigens can afford partial protection in rhesus monkeys against challenges with a stringent simian-human immunodeficiency virus. These mosaic vaccine antigens have been developed for optimal immunologic coverage of global HIV diversity.
Barouch and his team studied the immunogenicity of HIV mosaic Env/Gag/Pol antigens administered to monkeys using viral vectors. Env, Gag, and Pol are three major HIV proteins. After immunization, the monkeys were repetitively exposed to multiple simian-human immunodeficiency virus challenges and the investigators evaluated the ability of the vaccines to block infection.
Although most animals immunized with the mosaic HIV vaccine became infected by the end of the study, the researchers observed an 87 to 90 percent reduction in monkeys' probability of becoming infected each time they were exposed to the virus. In contrast, monkeys that received sham vaccines became infected more quickly.
"These findings indicate that these optimized vaccine antigens can afford partial protection in a stringent animal model," says Barouch.
The investigators found that the immunized monkeys mounted antibody responses against diverse strains of HIV noting, "Protection was dependent on several different types of antibody responses, suggesting that the coordinated activity of multiple antibody functions may contribute to protection against difficult-to-neutralize viruses." The monkeys also mounted cellular immune responses to multiple regions of the virus.
The researchers note that most previous HIV vaccine candidates have typically only been testedin monkeys for protection against easy-to-neutralize viruses rather than against a difficult-to-neutralize virus like the one used in this study. Also, each viral challenge in the study was approximately 100-fold more infectious than typical sexual HIV exposures in humans.
"These data suggest a path forward for the development of a global HIV vaccine and give us hope that such a vaccine might indeed be possible," said Barouch. "We are planning to advance this HIV vaccine candidate into clinical trials next year," he adds.
###
The vaccine regimen tested in the study has two components: The two Ad vaccines are based on the AdVac platform developed by Crucell Holland BV, one of the Janssen Pharmaceutical Companies of Johnson and Johnson, in collaboration with BIDMC. The MVA vaccine was developed by U.S. Military HIV Research Program (MHRP) scientists in collaboration with the National Institutes of Allergy and Infectious Diseases (NIAID) Laboratory of Viral Diseases.
Study coauthors include BIDMC investigators Kathryn E. Stephenson, Erica N. Borducchi, Kaitlin Smith, Kelly Stanley, Anna G. McNally, Jinyan Liu, Peter Abbink, Lori F. Maxfield, and Michael S. Seaman. Other coauthors are from the U.S. Military HIV Research Program (MHRP), the Los Alamos National Laboratory, Crucell Holland BV, and the Laboratory of Viral Diseases at the NIAID.
Support for this work was provided by the U.S. Military Research and Material Command and the U.S. Military HIV Research Program (W81XWH-07-2-0067); the National Institutes of Health (AI052074, AI060354, AI078526, AI084794, AI095985, AI096040, and AI00645); the NIAID Division of Intramural Research; the Ragon Institute of MGH, MIT, and Harvard; and the Bill and Melinda Gates Foundation.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and currently ranks third in National Institutes of Health funding among independent hospitals nationwide.
BIDMC has a network of community partners that includes Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Health Care, Commonwealth Hematology-Oncology, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of the Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.
Researchers design global HIV vaccine that shows promise in monkeys
Preclinical study provides strong rationale for clinical trials
2013-10-24
ELSE PRESS RELEASES FROM THIS DATE:
Genetic mutation provides clues to battling childhood obesity
2013-10-24
Genetic mutation provides clues to battling childhood obesity
As the number of children battling obesity continues to grow, researchers are racing to identify causes and possible interventions. Now, a new paper publishing October 24 in the journal Cell identifies a possible ...
Bee sting allergy could be a defense response gone haywire, Stanford scientists say
2013-10-24
Bee sting allergy could be a defense response gone haywire, Stanford scientists say
STANFORD, Calif. — For most people, a bee sting causes temporary pain and discomfort, but for those with a bee venom allergy, the consequences can be devastating: ...
Researchers identify gene variant that raises risk for colorectal cancer from eating processed meat
2013-10-24
Researchers identify gene variant that raises risk for colorectal cancer from eating processed meat
Discovery sets first step towards identification of genetic variants linked to carcinogenic risk from diet and nutrition
A common genetic variant that affects ...
Reservoir of hidden HIV larger than previously thought
2013-10-24
Reservoir of hidden HIV larger than previously thought
New findings put spotlight on need for new drugs to target HIV proviruses
In the fight to cure human immunodeficiency virus (HIV), researchers have been dealt a blow. A new study by Howard Hughes Medical Institute ...
Researchers apply brainpower to understanding neural stem cell differentiation
2013-10-24
Researchers apply brainpower to understanding neural stem cell differentiation
How do humans and other mammals get so brainy? USC researcher Wange Lu, PhD, and his colleagues shed new light on this question in a paper that will be published in Cell ...
Novel genetic mutations cause low metabolic rate and obesity
2013-10-24
Novel genetic mutations cause low metabolic rate and obesity
Researchers believe the gene could be a useful therapeutic target for treating obesity and type 2 diabetes
Researchers from the University of Cambridge have discovered a novel genetic cause of severe ...
For fish and rice to thrive in Yolo Bypass, 'just add water'
2013-10-24
For fish and rice to thrive in Yolo Bypass, 'just add water'
From a fish-eye view, rice fields in California's Yolo Bypass provide
an all-you-can-eat bug buffet for juvenile salmon seeking nourishment
on their journey to the sea. That's according ...
Physicists decode decision circuit of cancer metastasis
2013-10-24
Physicists decode decision circuit of cancer metastasis
Rice U. research reveals 3-way genetic switch for cancer metastasis
Cancer researchers from Rice University have deciphered the operating principles of a genetic switch that cancer cells use to decide when to metastasize and ...
Study shows no increased risk for heart attacks among HIV-positive patients with high CD4 cell count
2013-10-24
Study shows no increased risk for heart attacks among HIV-positive patients with high CD4 cell count
Healthy HIV-positive subjects have same heart-attack risk as general population
OAKLAND, Calif., October 24, 2013 — Patients who are HIV-positive and have high CD4 cell ...
Climate change and coevolution: We've done the math
2013-10-24
Climate change and coevolution: We've done the math
A rule of thumb to help calculate the likely effect of climate change where species interact
When scientists attempt to understand how climate change might reshape our environment, they must grapple ...
LAST 30 PRESS RELEASES:
Uncovering hyper-maturity and accelerated aging in the hippocampus
Earliest long-snouted fossil crocodile from Egypt reveals the African origins of seagoing crocs
Henna’s hidden healing: Treating fibrosis with a chemical derived from Lawsonia inermis
KIST demonstrates world's first ultra-precise, ultra-high-resolution distributed quantum sensor with 'entangled light'
Liver transplantation utilizing grafts donated after medical assistance in dying is feasible and has outcomes comparable to standard donation
Canada is failing the rising numbers of youth who use opioids
Opioid prescribing for pain is declining in Canada
Can inpatient care help address overdose crisis?
Discovering six new bat species is a treat for museum researchers
National emergency wakeup call as SEND support system crisis worsens – latest analysis shows
New drug-eluting balloon may be as safe and effective as conventional metal stents for repeat percutaneous coronary interventions
Effectiveness and cost-effectiveness of automated external defibrillators in private homes
University of Phoenix College of Social and Behavioral Sciences leadership publishes white paper on trauma-informed education
Microbial iron mining: turning polluted soils into self-cleaning reactors
Molecular snapshots reveal how the body knows it’s too hot
Analysis finds alarming rise in severe diverticulitis among younger Americans
Mitochondria and lysosomes reprogram immune cells that dampen inflammation
Cockroach infestation linked to home allergen, endotoxin levels
New biochar-powered microbial systems offer sustainable solution for toxic pollutants
Identifying the best high-biomass sorghum hybrids based on biomass yield potential and feedstock quality affected by nitrogen fertility management under various environments
How HIV’s shape-shifting protein reveals clues for smarter drug design
Study identifies viral combinations that heighten risk of severe respiratory illnesses in infants
Aboveground rather than belowground productivity drives variability in miscanthus × giganteus net primary productivity
Making yeast more efficient 'cell factories' for producing valuable plant compounds
Aging in plain sight: What new research says the eyes reveal about aging and cardiovascular risk
Child welfare system involvement may improve diagnosis of developmental delays
Heavier electric trucks could strain New York City’s roads and bridges, study warns
From womb to world: scientists reveal how maternal stress programs infant development
Bezos Earth Fund grants $2M to UC Davis and American Heart Association to advance AI-designed foods
Data Protection is transforming humanitarian action in the digital age, new book shows
[Press-News.org] Researchers design global HIV vaccine that shows promise in monkeysPreclinical study provides strong rationale for clinical trials